ReviewEULAR rheumatology open2026
Novel insights into the imaging of axial spondyloarthritis.
Review in EULAR rheumatology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Axial spondyloarthritis (axSpA) is a chronic immune-mediated disease primarily affecting the sacroiliac joints and spine. Imaging plays a central role in the diagnosis, classification, and disease monitoring of axSpA. In this manuscript, recent developments in imaging that enhance both early detection and the understanding of disease progression are presented and discussed. Key topics include the role of conventional radiographs and their accuracy in the identification of axSpA-related imaging findings, the role of magnetic resonance imaging (MRI) scans or other advanced imaging techniques in identifying inflammatory and structural lesions, and the significance of fat lesions as a marker of postinflammatory changes with the potential to predict new bone formation. Emerging applications of quantitative imaging and artificial intelligence in image analysis are also highlighted. Recent advances in imaging have significantly transformed the diagnostic landscape of axSpA. These insights support the integration of imaging as a biomarker for personalised treatment strategies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.